| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |